4Kscore Test: Predicting the Risk of Aggressive Prostate Cancer
ثبت نشده
چکیده
NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc., provide these Clinical Review Criteria for internal use by their members and health care providers. The Clinical Review Criteria only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Use of the Clinical Review Criteria or any Kaiser Permanente entity name, logo, trade name, trademark, or service mark for marketing or publicity purposes, including on any website, or in any press release or promotional material, is strictly prohibited.
منابع مشابه
4Kscore Test: Predicting the Risk of Aggressive Prostate Cancer
NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc., provide these Clinical Review Criteria for internal use by their members and health care providers. The Clinical Review Criteria only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Use of the Clinical Review Criter...
متن کامل4Kscore Test: Predicting the Risk of Aggressive Prostate Cancer
NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc., provide these Clinical Review Criteria for internal use by their members and health care providers. The Clinical Review Criteria only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Use of the Clinical Review Criter...
متن کاملThe 4kscore Test Predicts High Grade Prostate Cancer on Biopsy at Psa Levels < 4ng/ml
Introduction: The clinical value of PSA for prostate cancer early detection has been questioned primarily due to its poor specificity for clinically relevant disease, namely high grade prostate cancer. This is especially true at PSA levels lower than 4 ng/mL, generally considered to be within the normal range. However, PSA values between 1.54 ng/mL have been referred to as the PSA Danger Zone b...
متن کاملThe Case for Tailored Prostate Cancer Screening: An NCCN Perspective.
A preponderance of clinical evidence supports a significant public health benefit for screening and early detection of prostate cancer in selected men. The challenge lies in maximizing early diagnosis of potentially aggressive but curable disease while minimizing diagnosis and treatment of indolent disease. A tailored approach to population screening in appropriately counseled men, using an evi...
متن کاملWhom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.
This article describes markers used for prostate biopsy decisions, including prostrate-specific antigen (PSA), free PSA, the prostate health index, 4Kscore, PCA3, and ConfirmMDx. It also summarizes the use of nomograms combining multiple variables for prostate cancer detection.
متن کامل